Valued at $344.5M at its early-stage round, Oct 2025. Nothing has traded since.
- ·The complete investor list: 13 names
- ·Watch Soufflé Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Soufflé Therapeutics funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Oct 2025 | Early Stage VC (Series A) | $200.0M | ▮ | ▮ |
Membership and data by Private Market View
Soufflé Therapeutics valuation
Soufflé Therapeutics was valued at $345 million at its early-stage round in Oct 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Soufflé Therapeutics raised?
Soufflé Therapeutics has raised $241 million across 1 recorded round since 2025. The largest was a $200 million Series A in Oct 2025.
Comparable companies
Comparable therapeutic devices names by valuation on PrivateMarketView: Saluda Medical ($435 million), LightForce ($400 million) and Galvanize Therapeutics ($300 million).
How Soufflé Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Soufflé Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Soufflé Therapeutics
- What is Soufflé Therapeutics worth?
- Soufflé Therapeutics is valued at $344.5M as of Oct 2026. Valued at $344.5M at its early-stage round, Oct 2025. Nothing has traded since.
- How much has Soufflé Therapeutics raised?
- Soufflé Therapeutics has raised $240.6M in total funding across 1 recorded rounds.
- When did Soufflé Therapeutics last raise?
- Soufflé Therapeutics last raised in Oct 2025 (Early Stage VC (Series A)), raising $200.0M.